Sponsor Dossier

BioMarin Pharmaceutical

Sponsor Dossier for BioMarin Pharmaceutical. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.

Brand: BRINEURA
Brand: KUVAN
Brand: NAGLAZYME
Brand: PALYNZIQ
Brand: VIMIZIM
Brand: VOXZOGO

About

BioMarin Pharmaceutical is an Australian Private Company with ABN 69159743496, registered in NSW. The entity is active and registered for GST from 2012.

Portfolio

BioMarin Pharmaceutical has six brands on the ARTG, all of which are indexable and have Product Information on file. The portfolio includes BRINEURA, KUVAN, NAGLAZYME, PALYNZIQ, VIMIZIM, and VOXZOGO. All six brands have PBAC outcomes on record, and three brands have AusPARs on record. One brand is PBS-listed.

Therapeutic focus

— Rare Disease: 3 brands — Endocrinology: 3 brands

PBS footprint

One brand in the portfolio is PBS-listed, with the latest PBS schedule date being 2026-05-01.

Regulatory activity

The latest PBAC outcome for BioMarin Pharmaceutical is dated 2022-11-01, covering all six brands with PBAC outcomes on record. The latest AusPAR is dated 2022-06-29, covering three brands with AusPARs on record.

ABR record